When: Price at $445+ on heavy volume

Then: Consider re-engagement

SELL (reduce exposure 60-70%, tighter stop at $400, no re-engagement until sustained close below $385 with volume confirmation, yields stabilize, sell-side upgrade, and differentiated MariTide data)

• 5.5% upside to $445 requires stock to break resistance on tape where yields are rising, dividend support has evaporated, and the biggest near-term catalyst received a Neutral rating from Citi
• 10% downside to $380 requires one of several plausible catalysts — yield shock, guidance disappointment, competitive obesity readout, or mean reversion from 200 SMA — and these scenarios are not mutually exclusive
• 2.38% dividend yield falling below the 10-year Treasury signals the equity risk premium is being supported by momentum and positioning, not fundamentals — a setup that unwinds violently when positioning shifts
• P/E above 26 with yield below risk-free rate means income-investor support for the multiple has evaporated
• Obesity TAM bet is binary: market prices AMGN as category leader, so MariTide delivers leading readout (limited upside already priced), respectable-but-not-leading readout (stock gets hit), or failure/delay (stock gets crushed) — negative expected value setup
• Price 17% above 200 SMA represents stretched technicals that warrant more meaningful exposure reduction, not a half-trim
• Reload zone at $378-395 is described as 'hope, not a plan' — market timing dressed in tactical language
• In higher-for-longer macro regime with bond market actively breaking down, no guarantee $380 holds; stock can trade to $340 or lower on full re-rating if yields rip to 6% on 10-year, Fed stays locked at zero cuts, or obesity TAM gets more crowded
• Recommends 60-70% trim at current levels with tighter stop at $400 rather than aggressive analyst's $395
• No re-engagement until sustained close below $385 with volume confirmation, yields stabilize, sell-side upgrade above current spot, and MariTide delivers genuinely differentiated clinical readout

→ vs aggressive: Framing the 5.5% vs 10% asymmetry as 'asymmetric betting' or 'alpha generation' is marketing, not analysis — comparing single resistance touch against full multiple re-rating scenario is not a one-to-two risk-reward favoring bulls in any meaningful sense

→ vs aggressive: Describing reload zone at $378-395 as 'dry powder' and 'ammunition' is intellectually dishonest — that's hoping for a drawdown to buy back what they just sold, which is market timing dressed in tactical language, not risk management

→ vs aggressive: Wave-away of dividend falling below risk-free rate as 'relative-value issue' is wrong framing — it signals equity risk premium is supported by momentum, not fundamentals, which unwinds violently when positioning shifts

→ vs aggressive: Calling dividend hike 'optics, not substance' actually undermines their own bull case — if dividend hike isn't substantive, income-investor support for the multiple is also gone

→ vs aggressive: 30-50% trim doesn't adequately protect against binary obesity bet — if MariTide delivers anything other than category-leading readout, stock gets hit regardless

→ vs aggressive: Being 'too generous' on technicals — correctly noting price is 17% above 200 SMA and calling it 'stretched rubber band' but then defending 30-50% trim as executing on technical report's recommendation is backwards logic

→ vs aggressive: Internal inconsistency: if bull case is genuinely weak, if macro is a headwind, if valuation demands heroic growth, then half-trim leaves firm overexposed to all those risks simultaneously

→ vs aggressive: Framing this as 'aggressive' or 'alpha-generating' trade is optimizing for upside scenarios when downside scenarios are more probable, more correlated with each other, and less priced into the market than they're willing to admit

SELL (40-50% trim into $426-$440, tighter stop at $397-$398, technical re-engagement triggers)

• Q2 revenue up 9.5% YoY, EPS up 65% YoY, $8.65B trailing free cash flow, current ratio 1.37, net debt to EBITDA 2.5x
• Beta of 0.426 makes this a defensive name in macro downturns
• Dividend yield 2.38% covered ~2.5x by trailing FCF, raised 6%; below 10-year Treasury but absolute income floor exists
• Technical structure intact: long-term trend bullish, MACD curling bullishly, 50/10-day MAs as reliable support, September 8 gap fully recovered
• Trim 40-50% into $426-$440 zone; keep residual with stop at $397-$398
• Re-engage on pullback to $395-$405 on declining volume OR breakout above $445 on heavy volume—no sell-side upgrade or MariTide readout required
• Redeploy trim proceeds into shorter duration names, cash, or T-bills yielding above the dividend

→ vs aggressive: Calling a 30-50% trim 'alpha generation' is marketing copy, not analysis; the genuine alpha question is whether 30-50% is the right trim size, not framing it as aggressive

→ vs conservative: Advocating 60-70% off the table overshoots evidence—company has strong fundamentals, intact technicals, and defensive characteristics that provide a higher drawdown floor

→ vs conservative: Re-engagement framework requiring sustained close below $385 with volume PLUS sell-side upgrade PLUS differentiated MariTide readout is too restrictive; you'd miss the entire turn chasing three confirmations

→ vs conservative: Treating yield below 10-year Treasury as a market signal that multiple is supported only by positioning overstates the case; dividend is still covered ~2.5x by FCF with a real income floor